Terbinafine hydrochloride and Pancytopenia - a phase IV clinical study of FDA data

Summary:

Pancytopenia is reported only by a few people who take Terbinafine Hydrochloride.

The phase IV clinical study analyzes which people take Terbinafine hydrochloride and have Pancytopenia. It is created by eHealthMe based on reports of 990 people who have side effects while taking Terbinafine hydrochloride from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.



On Dec, 05, 2022

990 people reported to have side effects when taking Terbinafine hydrochloride.
Among them, 5 people (0.51%) have Pancytopenia.


What is Terbinafine hydrochloride?

Terbinafine hydrochloride has active ingredients of terbinafine hydrochloride. It is often used in fungal infection. eHealthMe is studying from 1,499 Terbinafine hydrochloride users for its effectiveness, alternative drugs and more.

What is Pancytopenia?

Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets) is found to be associated with 2,476 drugs and 2,337 conditions by eHealthMe.

Number of Terbinafine hydrochloride and Pancytopenia reports submitted per year:

Could Terbinafine hydrochloride cause Pancytopenia?

Time on Terbinafine hydrochloride when people have Pancytopenia *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Pancytopenia when taking Terbinafine hydrochloride *:

  • female: 25 %
  • male: 75 %

Age of people who have Pancytopenia when taking Terbinafine hydrochloride *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 0.0 %
  • 60+: 100 %

Common drugs people take besides Terbinafine hydrochloride *:

  1. Sporanox: 2 people, 40.00%
  2. Prednisolone: 2 people, 40.00%
  3. Levothyroxine Sodium: 2 people, 40.00%
  4. Furosemide: 2 people, 40.00%
  5. Fluconazole: 2 people, 40.00%
  6. Famotidine: 2 people, 40.00%
  7. Diazepam: 2 people, 40.00%
  8. Amphotericin B: 2 people, 40.00%
  9. Rilutek: 1 person, 20.00%
  10. Ondansetron: 1 person, 20.00%

Common side effects people have besides Pancytopenia *:

  1. Splenic Abscess (pus in spleen or near by): 2 people, 40.00%
  2. Skin Amp Subcutaneous Tissue Abscess (infection of the skin and subcutaneous tissue): 2 people, 40.00%
  3. Mitral Valve Incompetence (inefficient heart valve): 2 people, 40.00%
  4. Injection Site Pain: 2 people, 40.00%
  5. Urinary Tract Infection: 1 person, 20.00%
  6. Hypoxic-Ischaemic Encephalopathy (condition that occurs when the entire brain is deprived of an adequate oxygen supply, but the deprivation isn't total): 1 person, 20.00%
  7. Alanine Aminotransferase Increased: 1 person, 20.00%
  8. Aspartate Aminotransferase Increased: 1 person, 20.00%
  9. Blood Alkaline Phosphatase Increased: 1 person, 20.00%
  10. Bone Marrow Failure: 1 person, 20.00%

Common conditions people have *:

  1. Malignant Melanoma (skin cancer rises from melancytes): 1 person, 20.00%
  2. Epilepsy (common and diverse set of chronic neurological disorders characterized by seizures): 1 person, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Terbinafine hydrochloride and have Pancytopenia?

Check whether Pancytopenia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.



Related publications that referenced our studies

Related studies

How severe was Pancytopenia and when was it recovered:

Expand to all the drugs that have ingredients of terbinafine hydrochloride:

Alternative drugs to, pros and cons of Terbinafine hydrochloride:

Pancytopenia treatments and more:

COVID vaccines that are related to Pancytopenia:

Common drugs associated with Pancytopenia:

All the drugs that are associated with Pancytopenia:

Common conditions associated with Pancytopenia:

All the conditions that are associated with Pancytopenia:

How the study uses the data?

The study uses data from the FDA. It is based on terbinafine hydrochloride (the active ingredients of Terbinafine hydrochloride) and Terbinafine hydrochloride (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: